VitalHub acquires Buddy Healthcare for €8.6 million

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

VitalHub has acquired Finnish care coordination platform Buddy Healthcare for €8.6 million upfront, comprising €8.3 million in cash and 75,000 common shares. The deal includes potential earnouts of €4.5 million based on performance targets over the next two years. Buddy Healthcare reported Annual Recurring Revenue of €2.8 million as of June 30, 2026.

powered bylight_fuzz_icon
45492817

*this image is generated using AI for illustrative purposes only.

VitalHub has acquired Buddy Healthcare, a care coordination platform based in Finland, for total upfront consideration of €8.6 million. The transaction strengthens VitalHub's position in the Nordic healthcare market and expands its patient flow and patient engagement capabilities internationally. The acquisition was announced on July 13, 2026.

The purchase price paid at closing consisted of a cash payment of €8.3 million, subject to working capital adjustments, and the issuance of 75,000 common shares of VitalHub. Additionally, there is a potential performance-based consideration of up to €4.5 million payable in all-cash earnouts. These earnouts are contingent on the achievement of specific performance targets at the end of the first two calendar years following the acquisition.

Buddy Healthcare, established in 2016, provides a platform that digitalizes specialized care pathways. It replaces physical notes and phone calls with automated guidance to keep patients on track and free up hospital resources. The platform includes a web-based application for healthcare professionals and a mobile app for patients. As of June 30, 2026, Buddy Healthcare reported Annual Recurring Revenue of approximately €2.8 million and was approximately Adjusted EBITDA breakeven.

The acquisition establishes a strategic beachhead in the Nordic market through a platform with a growing customer base in the UK. VitalHub intends to leverage its existing customer relationships and commercial infrastructure to accelerate Buddy Healthcare's growth in the UK. The combined offering aims to improve access, coordination, and delivery of care.

"Buddy Healthcare represents a highly strategic addition to the VitalHub platform," said Dan Matlow, CEO of VitalHub. "The acquisition establishes a strong foundation for VitalHub in the Nordic region and strengthens our patient flow and patient engagement capabilities internationally."

Transaction Overview

Component Details
Total Upfront Consideration €8.6 million
Cash Payment €8.3 million
Shares Issued 75,000 common shares
Maximum Earnout €4.5 million
Annual Recurring Revenue €2.8 million

Jussi Määttä, CEO of Buddy Healthcare, stated that the mission has been to help care teams deliver more coordinated and efficient care through digital innovation. He expressed confidence that VitalHub is the ideal long-term home for the business, citing deep healthcare expertise and a strong international presence.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific performance targets must be met to trigger the full €4.5 million earnout?

How does VitalHub plan to integrate Buddy Healthcare's technology with its existing platform?

What is the projected timeline for achieving profitability and revenue growth in the Nordic market?

like17
dislike

VitalHub shareholders elect directors, appoint auditor at AGM

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

VitalHub Corp. held its annual general meeting on June 26, 2026, electing all six director nominees and appointing Ernst & Young LLP as auditor. With 58.21% of shares voted, all proposals passed with strong majority support.

powered bylight_fuzz_icon
44051977

*this image is generated using AI for illustrative purposes only.

VitalHub Corp. elected all director nominees and appointed Ernst & Young LLP as auditor at its annual general meeting held on June 26, 2026. The meeting, conducted virtually, saw 58.21% of the company's issued and outstanding shares participate in the voting process. Shareholders approved all proposals, including the election of six directors and the ratification of the auditor.

The company's board of directors was reconstituted with the election of Allan Brett, Stephen Garrington, Dan Matlow, Andrew Shen, Tony Shen, and Barry Tissenbaum. The voting results indicated strong shareholder support, with four directors receiving over 99% of votes cast. Tony Shen and Barry Tissenbaum received 82.91% and 81.85% of votes for, respectively.

Election of Directors

All nominees listed in the management information circular dated May 7, 2026, were elected. The table below details the voting results for each nominee.

Name of Nominee Votes For Votes For % Withheld Vote Withheld Vote %
Allan Brett 36,074,281 99.95% 17,020 0.05%
Stephen Garrington 35,760,687 99.08% 330,614 0.92%
Dan Matlow 35,773,837 99.12% 317,464 0.88%
Andrew Shen 35,940,095 99.58% 151,206 0.42%
Tony Shen 29,922,526 82.91% 6,168,775 17.09%
Barry Tissenbaum 29,539,336 81.85% 6,551,965 18.15%

Appointment of Auditors

Shareholders appointed Ernst & Young LLP as the company's auditor for the upcoming term. The directors were authorized to fix the auditor's remuneration. The appointment received 99.95% of votes cast, with 17,850 votes withheld.

Name of Auditor Votes For Votes For % Withheld Vote Withheld Vote %
Ernst & Young LLP 36,807,307 99.95% 17,850 0.05%

Total shares voted stood at 36,825,157 out of 63,259,564 total shares issued and outstanding. Final voting results on all matters will be available on SEDAR+ at www.sedarplus.com .

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What strategic priorities will the reconstituted board focus on in the upcoming fiscal year?

How will the company address the significant shareholder opposition regarding Tony Shen and Barry Tissenbaum?

What factors contributed to the lower voter turnout compared to previous annual general meetings?

like17
dislike

More News on VitalHub Corp.